HIV Diagnostics Market Competitive Landscape, Future Trends And Regional Forecast To 2028

The research report "HIV Diagnostics Market Analysis By Test (Antibody Tests, Viral Identification, CD4 Testing, Viral Load Testing, Others) End-User (Hospitals, Diagnostic Centers, Blood Banks, Home Care Settings) And Geography- Global/Region/Country Forecast to 2028." The global HIV diagnostics market size was estimated at USD 3.3 billion in 2021 and growing at a CAGR rate of 9.8% during the forecast period 2022-2028.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/global-hiv-diagnostics-market/

Increasing government initiatives bolsters the HIV diagnostics Market:
HIV spreads through when imparting needles to someone who is HIV infected, blood donation and sexual interactions. It spreads through body fluids. If it is not treated, cancer or tuberculosis like infections takes the benefit of weak immune system and results into AIDS. No effective cure presents for HIV at present however it can be controlled with proper medical care. Global HIV diagnosis market is growing steadily. Consciousness about early HIV diagnosis and available equipment and tests is created by government and non-government organizations. There is 0.8% prevalence of HIV in 2015 globally according to World Health Organization, WHO.

Increase in the government initiatives, rising number of blood donations and transfusions and advantages of point-of-care instruments and kits in which patients can be diagnosed even outside the laboratory setting are the factors fuel the HIV diagnostics market. Moreover, growing technological developments in disease diagnostic tests, commercialization and improvement of new regulatory approved point of care and rapid CD4, p24 antigen and EID tests are anticipated to bolster the HIV diagnostics market over the forthcoming years.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=15701

North America accounted for major share in the HIV Diagnostics Market:
On the basis of regional analysis, HIV diagnostics market is classified into major regions such as Latin America, North America, Asia Pacific, Europe, Middle East and Africa. Among all these regions North America witnesses leading revenue share in global HIV diagnostics market because of the increase in the demand for portable and diagnostic devices and fast adoption of technologically developed diagnostic solutions. In addition, increasing cases of HIV and obligatory execution of HIV screening tests are anticipated to fuel regional penetration of HIV diagnostics. Nearly 1.4 Mn people were infected with HIV/AIDS. Asia pacific HIV diagnostics market anticipated to grow at profitable rate due to the growing consciousness amid the population about HIV diagnostics and increase in the patients suffering from HIV/AIDS. South Africa has massive opportunity in the Middle East and Africa region because of the presence of a huge number of infected people as well as growing consciousness.

Competitive Analysis - HIV Diagnostics Market Analysis:
A few major players working in the HIV diagnostics market are F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Siemens Healthineers) (Germany), Merck KGaA (Germany) and Hologic, Inc. (U.S.). Key players in the market focus on following major strategies including collaborations and mergers to strengthen their product offering.

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=15701

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.